The City of Hope—Liberia, a hospital to tackle infertility among married couples and conduct deoxyribonucleic acid (DNA) testing is about to be established in the country.
By January next year, the hospital to be named the City of Hope—Liberia Fertility and DNA Hospital will be established, a statement from the office of Doctor Kenneth Frimpong, a Ghanaian doctor, who is the brain behind the establishment of the hospital.
Dr. Frimpong is a biotechnology professional, clinical embryologist and forensic DNA expert.
The City of Hope which has its headquarters in Accra, Ghana, is a multi-specialist medical research facility with a vision to provide world class molecular medicine around West Africa.
The hospital will have an executive clinic, providing convenient and accessible five star services catering to the medical needs of busy global business executive aged 50 and above who can afford to fly to West Africa for prostate, breast cancer care and comprehensive medical check-ups.
Dr. Frimpong is currently visiting Liberia on the invitation of a Liberian businessman, Joe-Gene Mulba, CEO of the Muson Group Incorporated.
Dr. Frimpong obtained his doctorate in biochemistry and molecular biology in the United States. He went on to perform medical research in HIV and Gene Therapy at the prestigious Salk Institute in California and at the University of California. He served under the mentorship of Nobel Prize Winner Dr. Francis Crick.
Frimpong told reporters in Monrovia yesterday that since the establishment of the hospital in Ghana in 2008, the City of Hope is being run by a group of scientists who are fully equipped and staffed to provide a complete set of DNA, molecular and medical tests for molecular cancer diagnosis and infertility treatment as well as treatments for other ailments.
He previously established the Scientllect Genetics and DNA Diagnostics Company, and is currently providing general prenatal genetic screening and DNA services to hospitals, universities and research organizations in the West African sub-region.
He said diabetes and hypertension care are among the many illnesses which hospitals without the requisite capacity to address refer their patients for laboratory services in countries like Ghana and South Africa. Liberia will no longer be lacking in these services when the hospital is launched, said Dr. Frimpong.
The City of Hope Hospital, according to Dr. Frimpong, will be fully equipped to perform sickle cell elimination and pre-implementation genetic diagnostics as is often done for patients in Ghana.
“We recently conducted a survey across Liberia’s 15 counties gathering first-hand information on the situation of married couples’ fertility problems,” Frimpong told reporters. He said the survey established that many relationships have fallen apart as a result of couples not bearing children. Dr. Frimpong expressed the hope that the establishment of the Fertility and DNA Testing Hospital will put an end to such problems.
“Liberian nurses have been interviewed and will travel to Ghana for training in the areas of fertility and DNA testing,” he said.
He said the solution to what is called ‘weak back problem’ will also be address once the hospital is established.
Mr. Mulbah in his remarks said he is saddened by the condition of Liberians who troop to churches seeking for divine intervention to bear children.
He said modalities are being worked out with health authorities of the Liberian government for the establishment of the City of Hope Hospital by next year.
“The hospital, when built, will serve as a referral and research center for the many Liberians who have had to travel to other countries in the Mano river sub-region and beyond (for specialized medical services),” Mr. Mulbah said.
Mulbah said love for country was what prompted his desire to work with the Ghanaian based hospital to ensure that those who go to church for fruit of the womb problems will have a solution to their problem.
Meanwhile, the City of Hope-Liberia has earmarked the Congo Town back road as a possible location for the hospital.